MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International Long Term Debt Current 2011-2026 | MTD
Annual Long Term Debt Current Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.1 M | 29.1 M | 28.5 M | 29.3 M | 30.6 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.1 M | 28.5 M | 30.5 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 29.7 | 3.74 % | $ 20 B |  Niderland |
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M |  USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 21.42 | -4.46 % | $ 1.14 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
662 K | $ 1.56 | 6.85 % | $ 2.08 M | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 25.05 | 2.0 % | $ 696 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 183.88 | 3.92 % | $ 9.11 B | USA |
 |
Danaher Corporation
DHR
|
199 M | $ 194.75 | 0.5 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 2.0 | -9.09 % | $ 8.85 M | USA |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 5.08 | 1.6 % | $ 470 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.35 | 2.33 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.51 | 2.92 % | $ 2.06 B | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 520.6 | 0.96 % | $ 15 B | USA |
 |
Illumina
ILMN
|
79 M | $ 134.5 | 1.34 % | $ 21.4 B | USA |
 |
Precipio
PRPO
|
410 K | $ 28.3 | -2.41 % | $ 45.4 M | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 16.26 | 0.81 % | $ 492 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 90.36 | 5.44 % | $ 11.3 B | USA |
 |
Senseonics Holdings
SENS
|
496 K | $ 6.77 | - | $ 282 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
41 K | $ 2.91 | 2.83 % | $ 94.4 K | USA |
 |
Soleno Therapeutics
SLNO
|
726 K | $ 52.78 | 0.4 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.18 | -0.91 % | $ 5.01 M | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 119.68 | 3.55 % | $ 9.87 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 270.68 | 1.62 % | $ 22.5 B | USA |
 |
Neuronetics
STIM
|
5.56 M | $ 1.42 | 1.43 % | $ 93.7 M | USA |
 |
Celcuity
CELC
|
54 K | $ 122.46 | -2.23 % | $ 5.73 B | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 83.82 | -0.12 % | $ 5.66 B | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 526.6 | 2.05 % | $ 199 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 195.02 | 1.86 % | $ 21.6 B | USA |
 |
ENDRA Life Sciences
NDRA
|
129 K | $ 6.4 | 23.79 % | $ 5.04 M | USA |